ST Germain D J Co. Inc. Cuts Position in The Cigna Group (NYSE:CI)

ST Germain D J Co. Inc. reduced its position in shares of The Cigna Group (NYSE:CI - Free Report) by 85.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 452 shares of the health services provider's stock after selling 2,635 shares during the quarter. ST Germain D J Co. Inc.'s holdings in The Cigna Group were worth $149,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Moody National Bank Trust Division raised its stake in The Cigna Group by 0.7% in the 1st quarter. Moody National Bank Trust Division now owns 4,587 shares of the health services provider's stock worth $1,509,000 after acquiring an additional 34 shares during the last quarter. Kesler Norman & Wride LLC raised its stake in The Cigna Group by 1.8% in the 4th quarter. Kesler Norman & Wride LLC now owns 2,033 shares of the health services provider's stock worth $562,000 after acquiring an additional 35 shares during the last quarter. Hudson Edge Investment Partners Inc. raised its stake in The Cigna Group by 1.9% in the 4th quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider's stock worth $520,000 after acquiring an additional 36 shares during the last quarter. Fifth Third Wealth Advisors LLC raised its stake in shares of The Cigna Group by 2.3% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 1,626 shares of the health services provider's stock valued at $535,000 after buying an additional 36 shares during the last quarter. Finally, Meridian Wealth Management LLC raised its stake in shares of The Cigna Group by 1.0% during the 4th quarter. Meridian Wealth Management LLC now owns 3,670 shares of the health services provider's stock valued at $1,013,000 after buying an additional 37 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Truist Financial lifted their price objective on The Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Wall Street Zen upgraded The Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Cowen reiterated a "buy" rating on shares of The Cigna Group in a research note on Monday, May 5th. Cantor Fitzgerald lifted their price objective on The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research note on Thursday, March 20th. Finally, Robert W. Baird reduced their price objective on The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $380.39.

The Cigna Group Price Performance

CI stock traded up $0.67 during trading on Thursday, hitting $310.79. The stock had a trading volume of 1,682,930 shares, compared to its average volume of 1,692,604. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The stock has a market capitalization of $83.03 billion, a P/E ratio of 25.39, a PEG ratio of 0.98 and a beta of 0.47. The company's 50-day moving average price is $324.14 and its two-hundred day moving average price is $309.30.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The company had revenue of $65.45 billion for the quarter, compared to analysts' expectations of $60.39 billion. During the same period in the previous year, the firm posted $6.47 EPS. The Cigna Group's revenue was up 14.4% compared to the same quarter last year. As a group, research analysts predict that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 1.94%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is currently 33.44%.

Insider Transactions at The Cigna Group

In other The Cigna Group news, insider Noelle K. Eder sold 9,944 shares of the business's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $320.00, for a total value of $3,182,080.00. Following the sale, the insider now owns 13,406 shares of the company's stock, valued at $4,289,920. The trade was a 42.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Elder Granger sold 2,376 shares of the business's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares in the company, valued at approximately $1,697,924.85. The trade was a 30.28% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.70% of the company's stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.